CBI Files Charge Sheet Against RML Hospital Cardiologist, Suppliers For Bribery

New Delhi: The CBI has filed a charge sheet against Ram Manohar Lohia Hospital cardiologist Parvatagouda Channappagouda, middlemen and surgical equipment suppliers in connection with the alleged bribery in recommending their stents and other paraphernalia for surgery, officials said Wednesday.

In addition to Assistant Professor Parvatagouda, the CBI has also named equipment suppliers Naresh Nagpal of Nagpal Technologies, Abrar Ahmed of Scienmed, sales manager of Biotroniks Akarshan Gulati and his colleague Monika Sinha, and others.

In its charge sheet filed before a special CBI court here within 60 days of busting the alleged bribery ring at the RML Hospital, the agency invoked Indian Penal Code section 120-B (criminal conspiracy) and provisions of the Prevention of Corruption Act pertaining to bribery, they said.

The CBI busted the ring operating at multiple levels at the hospital on May 9, arresting nine persons, including Parvatagouda.

The CBI had also arrested cardiology Professor Ajay Raj, clerks Bhuval Jaiswal and Sanjay Kumar, the hospital’s Cath Lab in-charge Rajnish Kumar, middleman Vikas Kumar, and medical equipment suppliers Naresh Nagpal of Nagpal Technologies, Bharat Singh Dalal of Bharti Medical Technologies, and Abrar Ahmed of Scienmed.

The probe into roles of other accused is still ongoing and the agency may file supplementary charge sheets in the case, they said.

The CBI FIR had alleged that Parvatagouda was collecting bribes from medical equipment and stent suppliers to recommend their products to the patients under treatment at the government hospital.

Parvatagouda had allegedly asked medical suppliers to pay the bribes he was supposed to get as early as possible. On May 2, he asked Nagpal to pay a bribe of Rs 2.48 lakh, which the latter assured him would be done, according to the CBI.

The CBI claimed that Parvatagouda also asked Ahmed on April 23 to pay all bribes as soon as possible because he was going on a summer vacation to Europe. The CBI has alleged that Ahmed had earlier made the payment of Rs 1.95 lakh in an account operated by Parvatagouda’s father Basant Gauda in March.

He allegedly made a similar demand to another medical supplier Akarshan Gulati, who told the doctor that one of his employees would make the payments. Parvatagouda contacted the employee and asked her to pay Rs 36,000 through UPI and the remaining in cash, the probe agency had said.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks